WO2015128718A1 - Novel economic process for vildagliptin - Google Patents

Novel economic process for vildagliptin Download PDF

Info

Publication number
WO2015128718A1
WO2015128718A1 PCT/IB2015/000219 IB2015000219W WO2015128718A1 WO 2015128718 A1 WO2015128718 A1 WO 2015128718A1 IB 2015000219 W IB2015000219 W IB 2015000219W WO 2015128718 A1 WO2015128718 A1 WO 2015128718A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
compound
acid
group
process according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2015/000219
Other languages
English (en)
French (fr)
Inventor
Swapnil Surendra Mohile
Sandeep Rameshrao TAPKIR
Manoj Vinayak PATIL
Ashok Kumar Gangopadhyay
Peter David Nightingale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hikal Ltd
Original Assignee
Hikal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hikal Ltd filed Critical Hikal Ltd
Priority to KR1020167024966A priority Critical patent/KR20160127025A/ko
Priority to JP2016552264A priority patent/JP2017507934A/ja
Priority to EP15754784.5A priority patent/EP3110795A4/de
Priority to CN201580010486.XA priority patent/CN106029635A/zh
Publication of WO2015128718A1 publication Critical patent/WO2015128718A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/26Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing carboxyl groups by reaction with HCN, or a salt thereof, and amines, or from aminonitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/14Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/24Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
    • C07C255/25Aminoacetonitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/70Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74Adamantanes

Definitions

  • the present invention relates to a commercially viable novel process for manufacturing Vildagliptin in high yield with hi h chemical and chiral purity.
  • Vildagliptin is chemically known as l-[ ⁇ (3-hydroxy-l-adamantyl)amino ⁇ acetyl]-2-cyano(s)- pyrrolidine, which is a dipeptidylpeptidase IV (DPP-IV) inhibitor and found usefulness in the treatment of diabetes mellitus.
  • DPP-IV dipeptidylpeptidase IV
  • PCT Patent Publication WO 01/96295A2 the method described involve chloroacetylation in THF followed by dehydration with TFAA.
  • PCT Patent Publication WO 2006/10.0181 a process for the synthesis of l-(haloacetyl)-2- cyano pyrroloine is described wherein the proline amide was coupled with chloroacetyl chloride followed by dehydration of amide using Vilsmeier reagent and its variants e.g., POCl 3 -DMF, SOCl 2 -DMF, cyanuric chloride-DMF etc).
  • the main object of the present invention is to provide an improved process for the preparation of a compound of formula (I), which is simple, economical, user- friendly and commercially viable.
  • Another objective of the present invention is to provide a process for the preparation of a compound of formula (I), which would be easy to implement on commercial scale, and to avoid excessive use of reagent(s) and organic solvent(s), which makes the present invention eco-friendly as well.
  • Yet another objective of the present invention is to provide a process for the preparation of a compound of formula (I) in a greater yield with higher chemical purity.
  • Still another objective of the present invention is to provide a process for the preparation of a compound of formula (I), wherein the byproduct formed during the reaction can be reusable and thereby recyclable, which makes the process industrially more suitable.
  • the present invention provides an improved process for the preparation of Vildagliptin of formula (I),
  • R 2 is H using a suitable dehydrating agent in a suitable solvent
  • the substituent Ri is considered to constitute C[-C 3 linear, cyclic or branched chain or C7-C 1 0 alkyl aryl group;
  • R 2 is defined as H, C 2 -C 6 alkyl group containing a double bond optionally substituted with halogen (such as CI, Br, I etc), S, O, Si etc. or a group containing C 7 -C 1 0 alkyl aryl optionally substituted by atoms selected from N, O, S, halogen Si etc.
  • R 3 is defined as CpC 6 alkyl group optionally substituted with one or more atoms selected from among halogen (such as F, CI etc), S, O, Si or a group containing C 7 -C 15 alkyl aryl (monocyclic or polycyclic) both the types are optionally substituted by one or more atom(s) selected from N, O, S, halogen Si etc.
  • halogen such as F, CI etc
  • R4 is chosen from C 6 -C] 0 aryl or heteroaryl group optionally substituted with F, CI, N0 2 and the like;
  • X is halogen (CI, Br, I), CH 3 S0 2 , PhS0 2 , 4-Me- PhS0 2 and the like.
  • the present invention provides an improved process for the preparation of Vildagliptin of formula (I) via novel synthetic approach.
  • step (a) step (c) and step (f) are preferably selected from the group consisting of ethyl acetate, isopropyl acetate, dichloro methane, chloroform, tetrahydrofuran, 2-methyl tetrahydrofuran, acetonitrile, dioxane, dimethyl formamide, acetone and the like or the mixture thereof; more preferably dichloro methane or ethyl acetate or dimethyl formamide or acetone.
  • step (a), step (d), step (1) and step (m) are preferably selected from organic base or an inorganic base, which are selected from the group consisting of triethyl amine, diisopropylethyl amine, pyridine, potassium carbonate, sodium carbonate, sodium bicarbonate, potassium bicarbonate, alkali or alkaline earth metal hydroxides such as sodium hydroxide, potassium hydroxide, more preferably is potassium carbonate or sodium carbonate or triethyl amine.
  • the said catalyst in step (a) and step (m) is a phase transfer catalyst and or alkali metal iodides such as sodium iodide or potassium iodide and the like to accelerate the said reaction.
  • step (a) is carried out preferably at ambient temperature to reflux temperature, more preferably at reflux temperature, whilest most preferably at 40 °C to 80°C.
  • step (b) wherein the solvent used in step (b) are preferably selected from the group consisting of water, methanol, ethanol, isopropyl alcohol, n-butyl alcohol or a mixture thereof, more preferably water or methanol or a mixture thereof.
  • the said reaction of step (b) are carried out preferably at ambient temperature to 120°C, more preferably at 45°C to 1 10°C, most preferably at reflux temperature of the solvent.
  • step (b) are preferably selected from hydrochloric acid, sulfuric acid, nitric acid and the like, more preferably is hydrochloric acid.
  • the said base in step (b) are preferably selected from alkali or alkaline earth metal hydroxides selected from lithium hydroxide, sodium hydroxide, potassium hydroxide, calcium hydroxide, magnesium hydroxide, barium hydroxide, C C 5 quaternary ammonium hydroxide and the like, more preferably is sodium hydroxide.
  • the reagent for N protection in step (d) are preferably selected from the group consisting of methyl chloroformate, ethyl chloroformate, isobutyl chloroformate, carbobenzoxy chloride, di-t-butyl dicarbonate, 2,2,2- trifluoroethyl chloroformate, aryl sulfonyl chloride and the like, more preferably di-t-butyl dicarbonate under the standard reaction condition known for those skilled in the art.
  • the solvent used in step (d) are preferably selected from the group consisting of water, methanol, ethanol, isopropyl alcohol, dichloro methane, acetonitrile, tetrahydrofuran, 2-methyl tetrahydrofuran, dioxane or a mixture thereof, more preferably water or methanol or dichloro methane or isopropyl alcohol or a mixture thereof.
  • step (c) and step (f) can be selected from the prior knowledge which is well understood by those skilled in the organic synthesis. More preferably in step (c) and step (f) is propylphosphonic anhydride is used.
  • step (c) and step (f) are carried out preferably at the temperature in the range between - 20°C to 100°C.
  • the said ammonia is either liquid ammonia or 10 to 50 % alcoholic solution of ammonia.
  • step (e) and step (g) are preferably selected from the alcoholic solvent and group consisting of methanol, ethanol, n-propanol, isopropyl alcohol, n-butanol and the like or a mixture thereof, more preferably methanol.
  • step (e) and step (g) are carried out preferably at the temperature in the range of ambient to 100°C.
  • step (h) and step (j) are preferably selected from the group consisting of phosphorus pentoxide, phosphoryl chloride, thionyl chloride, oxalyl chloride, cyanuric chloride, trifluoroacetic acid-N,N-dicyclohexylcarbodiimide, acetic anhydride, trifluoroacetic anhydride, polyphosphoric acid, propylphosphonic anhydride and the like optionally in combination with additives selected from the group consisting of pyridine, triethylamine, ⁇ , ⁇ -diisopropylethylamine, l,8-Diazabicyclo[5.4.0]undec-7-ene, 1,5-Diazabicyclo[4.3.0] non-5-ene, l,5-Diazabicyclo[4.3.0]non-5-ene imidazole, dimethyl sulfoxide, 4- dimethylamino
  • step (h), step (i) step (j), step (k) and step (1) are preferably selected from the group consisting of acetone, dichloro methane, chloroform, esters, tetrahydrofuran, 2-methyl tetrahydrofuran, dimethyl formamide, methyl isobutyl ketone, acetone, acetonitrile, toluene, cyclohexane, tert butyl methyl ether, 1 ,4-dioxane, dimethyl sulfoxide and the like or combination thereof, more preferably selected from the group consisting of dichloro methane, tetrahydrofuran, 2-methyl tetrahydrofuran or combination thereof.
  • step (h) and step (j) are carried out preferably at 0°C to 100°C, more preferably at ambient to 50°C.
  • the said dehydrating agent used in step (i) is preferably selected from the group consisting of phosphorus pentoxide, phosphoryl chloride, oxalyl chloride, cyanuric chloride, trifluoroacetic acid-N,N- dicyclohexylcarbodiimide, acetic anhydride, trifluoroacetic anhydride, polyphosphoric acid, propylphosphonic anhydride and the like optionally in combination with additives selected from pyridine, triethylamine, ⁇ , ⁇ -diisopropylethylamine, l,8-Diazabicyclo[5.4.0]undec-7- ene, l,5-Diazabicyclo[4.3.0]non-5-ene, l,5-Diazabicyclo[4.3.0]non-5-ene imidazole, pyridine, sodium acetate, potassium acetate, sodium formate, more preferably the preferred dehydrating rea
  • step (i) is carried out preferably at 0°C to 100°C, more preferably at ambient to 60°C.
  • the said reagent used in step (k) and (1) are preferably selected in suitable molar ratios from the group consisting of hydrochloric acid, hydrobromic acid, boron tribromide, formic acid, acetic acid, para toluene sulfonic acid, trifluoro acetic acid, trifluoromethan sulfonic acid, piperidine, pyridine, thioanisole, zinc, zinc chloride, alumunium chloride nBu 4 N + F ⁇ , N-bromosuccinimide, N-chlorosuccinimide, hydrogen/nickel, hydrogen / palladium on carbon, Rhodium on carbon, hydrogen/palladium- barium sulfate, hydrogen/palladium-calcium carbonate and the like or in suitable, combination thereof.
  • the solvent used in step (m) is preferably selected from the group consisting of water, alcohols, acetone, ethyl acetate, isopropyl acetate, dichloro methane, chloroform, tetrahydrofuran, 2-methyl tetrahydrofuran, acetonitrile, dioxane, dimethyl formamide, toluene, cyclohexane, cyclohexane, chlorobenzene, dichlorobenzene and the like or combination thereof, more preferably selected from the group consisting of dichloro methane, tetrahydrofuran, 2 -methyl tetrahydrofuran or combination thereof, more preferably dichloro methane, toluene or ethyl acetate.
  • step (m) is carried out preferably at ambient temperature to 100°C or reflux temperature, more preferably at ambient to 80°C.
  • present inventor have surprisingly found an impurity of a compound of formula (16), wherein the definition of Ri is defined earlier. Moreover the removal process of the said impurity is also suggested by the present invention.
  • the said impurity is characterized by the known methods in the prior art.
  • the acid used is selected from the group consisting of acetic acid, formic acid, citric acid, tartaric acid, para toluene sulfonic acid, methanesulfonic acid and the like, more preferably acetic acid.
  • step (n) is carried out by procedure described for step (d).
  • step (o) is carried out by procedure described for step (1).
  • TP In a clean and dry 5.0 L 4 necks RBF equipped with liquid addition funnel, TP. Charged cone, sulphuric acid (300 mL, 2 V) and cooled the reaction mass to 5-10 °C. To the cooled mass 1-adamantyl amine (150 g, 1 eq.) was added lot wise at 5-10 °C. After complete addition, stirred the reaction mass to get clear (slightly hazy) solution and maintained the reaction mass at 5-15 °C. Meanwhile a nitrating mixture was prepared by adding 150 mL of 65-70 % nitric acid to 450 mL cone, sulphuric acid maintaining temperature at 0-10 °C).
  • the nitrating mixture was added to the reaction mass maintaining reaction temperature at 20 ⁇ 5 °C. After the addition was over, stirred the reaction mass at 20 ⁇ 5°C for 3 to 5 h. Completion of the reaction was confirmed by GC.
  • the reaction mass was cooled to 0 - 5 °C and added water (150 mL, I V) to the reaction mass maintaining 0-20 °C and again cooled reaction mass to 5-10 °C. Second lot of water (300 mL, 2 V) was added to the reaction mass maintaining 5-20 °C. The reaction mass was cooled again to 5-10 °C and added third lot of water (1050 mL, 7 V) to the reaction mass maintaining 5-20 °C.
  • reaction mass Cooled reaction mass to 35-40°C under N 2 and applied vacuum slowly. Methanol was distilled completely under reduced pressure. After complete removal of methanol, heated reaction mass (stirable thick oil) at 45 °C under reduced pressure for 30 min. Charged above crude product into 2 L RBF and rinsed with water (700 mL, 7 V) and stirred to dissolve. The reaction mass was cooled to 10-15°C and potassium bicarbonate (260.50 g, 3.0 eq.) was added carefully. After complete addition of potassium bicarbonate, stirred reaction mass for 5-10 min. Charged chloroacetyl chloride (103.6 mL, 1.50 eq.) slowly maintaining below 10°C.
  • acetic acid (30.2 mL, 3.1 eq.) in water (175 mL, 5 V) was added to above reaction mass. The reaction mass was stirred for 30 min. at 20-25°C. The organic layer and aq. Layer were separated. The organic layer was kept aside. The aqueous layer was extracted with dichloromethane (70 mL x 4, 2V x 4). [Collectively organic layers were concentrated to get a compound of formula (16) wherein the Rl is specifically methyl]. After dichloromethane wash, adjusted the pH of aqueous layer using aq. ammonia (3V). The aqueous layer was extracted with dichloromethane (70 mL ⁇ 4, 2V ⁇ 4).
  • Example 12.2 (S)-l-[2-(3-Hydroxy-adamantan-l-ylamino)-acetyl]-pyrrolidine-2- carboxylic acid amide.
  • Examplel4 [2-((S)-2-Carbamoyl-pyrrolidine-l-yl)-2-oxo-ethyI]-(3-hydroxy-damantan-l- yl)-carbamic acid tert butyl ester
  • the crude was further purified by crystallization by dissolving under reflux with ethyl acetate (255 mL, 6V w.r.t to crude wt.) and IPA (85 mL, 2V) and crude compound (42.4 g) under stirring It was allowed to cool to 20-25°C and then to 0-5°C and stirred for 1 h at 0-5°C. Filtered the solid formed and washed with chilled ethyl acetate (42.5 mL, 1 V).
  • the 2-Me THF layer was concentrated to isolate crude product.
  • aqueous citric acid solution citric acid - 98 g, 3.0 eq; water - 6V
  • DCM DCM extract obtained above
  • DCM-3 DCM extract obtained above
  • DCM DCM
  • the crude material (26.4 g) was dissolved by refluxing in ethyl acetate (158.4 mL, 6 V w.r.t to crude wt.) and IPA (52.8 mL, 2V) under stirring maintaining for 2 h. Cooled the reaction mass to 20-25°C and then to 0-5 °C and stirred for 1 h. Filtered the solid formed and wash with chilled ethyl acetate (26.4 mL, IV) dried the solid obtained for 3-4 h at 50°C in tray dryer. Unload the solid and weighed.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
PCT/IB2015/000219 2014-02-28 2015-02-24 Novel economic process for vildagliptin Ceased WO2015128718A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
KR1020167024966A KR20160127025A (ko) 2014-02-28 2015-02-24 빌다글립틴의 신규하고 경제적인 제조
JP2016552264A JP2017507934A (ja) 2014-02-28 2015-02-24 ビルダグリプチンのための新規な実用的プロセス
EP15754784.5A EP3110795A4 (de) 2014-02-28 2015-02-24 Neuartiges ökonomisches verfahren für vildagliptin
CN201580010486.XA CN106029635A (zh) 2014-02-28 2015-02-24 用于维达列汀的新的经济的方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN708/MUM/2014 2014-02-28
IN708MU2014 2014-02-28

Publications (1)

Publication Number Publication Date
WO2015128718A1 true WO2015128718A1 (en) 2015-09-03

Family

ID=54008237

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2015/000219 Ceased WO2015128718A1 (en) 2014-02-28 2015-02-24 Novel economic process for vildagliptin

Country Status (5)

Country Link
EP (1) EP3110795A4 (de)
JP (1) JP2017507934A (de)
KR (1) KR20160127025A (de)
CN (1) CN106029635A (de)
WO (1) WO2015128718A1 (de)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106432026A (zh) * 2016-09-12 2017-02-22 重庆医科大学 一类对糖尿病具有潜在治疗活性的化合物
CN112279809A (zh) * 2020-09-23 2021-01-29 山东省海洋化工科学研究院 一种2-氰基-4-氟吡啶的制备方法
WO2021116897A1 (en) * 2019-12-10 2021-06-17 Optimus Drugs (P) Ltd Process for the preparation of vildagliptin
WO2022003405A1 (en) 2020-07-03 2022-01-06 Savoi Guilherme One-pot process to obtain a pyrrolidine-2-carbonitrile intermediate compound and industrial scale telescopic process to prepare (2s)-1-[n-(3-hydroxyadamantan-1-yl)glycyl]-2-pyrrolidinecarbonitrile (vildagliptin) using same
CN115108939A (zh) * 2021-03-17 2022-09-27 成都施贝康生物医药科技有限公司 反式-4-[(2-氨基-3,5-二溴苄基)氨基]-金刚烷-1-醇的中间体及制法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107033054A (zh) * 2017-06-19 2017-08-11 河北富格药业有限公司 一种维格列汀的合成方法
CN107325010A (zh) * 2017-08-14 2017-11-07 四川众邦制药有限公司 一种金刚烷醇的安全制备方法及装置
CN112939837B (zh) * 2021-02-03 2022-07-19 海南通用三洋药业有限公司 一种多相复式连续生产制备维格列汀的方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007078990A2 (en) * 2005-12-23 2007-07-12 Zealand Pharma A/S Modified lysine-mimetic compounds
WO2008084383A2 (en) * 2007-01-10 2008-07-17 Medichem, S.A. Process for preparing vildagliptin
EP2145873A1 (de) * 2008-06-17 2010-01-20 Commissariat A L'energie Atomique Neue Verbindungen, die eine Schutzaktivität gegen die Wirkung von Toxinen und Viren über einen intrazellulären Wirkungsmechanismus entfalten
WO2012004210A1 (en) * 2010-07-06 2012-01-12 Chemelectiva Srl Process and intermediates for preparation of an active ingredient
CN103450083A (zh) * 2013-09-13 2013-12-18 杭州华东医药集团生物工程研究所有限公司 格尔德霉素衍生物及其制备方法和用途
CN103980175A (zh) * 2013-02-07 2014-08-13 山东威智医药工业有限公司 制备维达列汀的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002360732A1 (en) * 2001-12-26 2003-07-24 Guilford Pharmaceuticals Change inhibitors of dipeptidyl peptidase iv
GB2445746A (en) * 2007-01-17 2008-07-23 Texcontor Ets Use of carbonated water as a solvent for freeze drying, and method of purification comprising dissolution of material in carbonated water and freeze drying
WO2011101861A1 (en) * 2010-01-29 2011-08-25 Msn Laboratories Limited Process for preparation of dpp-iv inhibitors
ITMI20112224A1 (it) * 2011-12-06 2013-06-07 Chemelectiva S R L Nuovo processo ed intermedi per la sintesi di vildagliptin

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007078990A2 (en) * 2005-12-23 2007-07-12 Zealand Pharma A/S Modified lysine-mimetic compounds
WO2008084383A2 (en) * 2007-01-10 2008-07-17 Medichem, S.A. Process for preparing vildagliptin
EP2145873A1 (de) * 2008-06-17 2010-01-20 Commissariat A L'energie Atomique Neue Verbindungen, die eine Schutzaktivität gegen die Wirkung von Toxinen und Viren über einen intrazellulären Wirkungsmechanismus entfalten
WO2012004210A1 (en) * 2010-07-06 2012-01-12 Chemelectiva Srl Process and intermediates for preparation of an active ingredient
CN103980175A (zh) * 2013-02-07 2014-08-13 山东威智医药工业有限公司 制备维达列汀的方法
CN103450083A (zh) * 2013-09-13 2013-12-18 杭州华东医药集团生物工程研究所有限公司 格尔德霉素衍生物及其制备方法和用途

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"acetyl]-2-cyano-(S)-pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties", JOURNAL OF MEDICINAL CHEMISTRY, vol. 46, no. Issue 13, 1 January 2003 (2003-01-01), pages 2774 - 2789, XP002663718 *
KI DONG ET AL.: "Synthesis, SAR, and X-ray structure of novel potent DPPIV inhibitors", OXADIAZOLYL KETONES, BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 17, 21 May 2007 (2007-05-21), pages 4167 - 4172, XP022144667 *
MOISEEV ET AL.: "Synthesis and antiviral activity of new adamantane derivatives", PHARMACEUTICAL CHEMISTRY JOURNAL, vol. 45, no. Issue 10, 8 February 2012 (2012-02-08), pages 588 - 592, XP055220245 *
See also references of EP3110795A4 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106432026A (zh) * 2016-09-12 2017-02-22 重庆医科大学 一类对糖尿病具有潜在治疗活性的化合物
WO2021116897A1 (en) * 2019-12-10 2021-06-17 Optimus Drugs (P) Ltd Process for the preparation of vildagliptin
WO2022003405A1 (en) 2020-07-03 2022-01-06 Savoi Guilherme One-pot process to obtain a pyrrolidine-2-carbonitrile intermediate compound and industrial scale telescopic process to prepare (2s)-1-[n-(3-hydroxyadamantan-1-yl)glycyl]-2-pyrrolidinecarbonitrile (vildagliptin) using same
CN112279809A (zh) * 2020-09-23 2021-01-29 山东省海洋化工科学研究院 一种2-氰基-4-氟吡啶的制备方法
CN115108939A (zh) * 2021-03-17 2022-09-27 成都施贝康生物医药科技有限公司 反式-4-[(2-氨基-3,5-二溴苄基)氨基]-金刚烷-1-醇的中间体及制法

Also Published As

Publication number Publication date
JP2017507934A (ja) 2017-03-23
EP3110795A4 (de) 2017-10-04
KR20160127025A (ko) 2016-11-02
CN106029635A (zh) 2016-10-12
EP3110795A1 (de) 2017-01-04

Similar Documents

Publication Publication Date Title
EP3110795A1 (de) Neuartiges ökonomisches verfahren für vildagliptin
US7893103B2 (en) Processes for the preparation of DPP IV inhibitors
KR101577159B1 (ko) 단맛 향상제의 제조 방법 및 중간체
US8741927B2 (en) Production method of intermediate compound for synthesizing medicament
RU2730006C1 (ru) Способ получения 5r-[(бензилокси)амино]пиперидин-2s-карбоновой кислоты или её производного
CN101955457A (zh) 光学活性3-氨基吡咯烷、3-氨基哌啶烷及其衍生物的一种通用制备方法
IL323810A (en) Synthesis of ras inhibitors
KR20210066768A (ko) 광학 활성 다이아민 유도체 및 티아졸 유도체의 생산을 위한 새로운 합성경로
WO2020222158A1 (en) Process for the preparation of 2-amino-n-(2,2,2-trifluoroethyl)-acetamide and salts thereof
RU2499792C2 (ru) Усовершенствованный способ получения ингибитора дипептидилпептидазы-iv и промежуточного соединения
WO2015145467A1 (en) An improved process for preparing vildagliptin
US7915427B2 (en) Process for producing aminoacetyl pyrrolidine carbonitrile derivative and intermediate for production thereof
WO2014145507A1 (en) A process for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof
WO2024092892A1 (zh) 依度沙班中间体及其制备方法
ES2986976T3 (es) Procedimiento para la preparación de ácido (R)-4-(1-(6-(4-(trifluorometil)bencil)-6-azaespiro[2.5]octano-5-carboxamido)-ciclopropil)benzoico o una sal del mismo
JP2014240399A (ja) イソキノリン誘導体又はその塩の新規製造方法
Huang et al. A facile approach to trans-4, 5-pyrrolidine lactam and application in the synthesis of nemonapride and streptopyrrolidine
WO2015110886A1 (en) A process for preparation of (2s, 5r)-7-oxo-n-[(3s)-pyrrolidin-3-yloxy]-6-(sulfooxy)-1,6-diazabicyclo [3.2.1]octane-2-carboxamide
KR20160024875A (ko) 피롤리딘-2-카르복실산 유도체를 위한 제조 방법
EP1781607A2 (de) Pyrrolidinderivate als antagonisten des muscarinrezeptors
WO2012022994A1 (en) Preparation process of vildagliptin
CN111138341A (zh) 一种沙格列汀的制备方法
KR100896087B1 (ko) 광학적으로 순수한 2-메틸피롤리딘 및 그 염의 제조방법
KR101325589B1 (ko) 1-알킬-2-(2-아미노에틸)피롤리딘의 제조방법
CN115650984A (zh) 一种安那格列汀的制备方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15754784

Country of ref document: EP

Kind code of ref document: A1

REEP Request for entry into the european phase

Ref document number: 2015754784

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2015754784

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2016552264

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112016019421

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 20167024966

Country of ref document: KR

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 112016019421

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20160823